Published in
Elsevier, Multiple Sclerosis and Related Disorders, (63), p. 103892, 2022
DOI: 10.1016/j.msard.2022.103892
Links
Tools
Real-world study of relapsing-remitting multiple sclerosis patients treated with Teriflunomide in Nordic countries: Quality-Of-Life, efficacy, safety and adherence outcomes
Journal article published in 2022 by
Anne Lise K. Hestvik 
,
Jette Lautrup Frederiksen ,
Helle Hvilsted Nielsen,
Øivind Torkildsen,
Camilla Eek,
Yumin Huang-Link,
Sara Haghighi,
Jon A. Tsai,
Matthias Kant
,
Jette Lautrup Frederiksen ,
Helle Hvilsted Nielsen,
Øivind Torkildsen,
Camilla Eek,
Yumin Huang-Link,
Sara Haghighi,
Jon A. Tsai,
Matthias Kant
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 